HomeInsightsStock Comparison

Glenmark Pharmaceuticals Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Glenmark Pharmaceuticals Ltd vs Sun Pharma Advanced Research Company Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Glenmark Pharmaceuticals Ltd is ₹ 2201 as of 16 Jul 15:22.
  • The P/E Ratio of Glenmark Pharmaceuticals Ltd changed from 7.5 on March 2020 to 0 on March 2024 . This represents a CAGR of -100.00% over 5 yearsThe P/E Ratio of Sun Pharma Advanced Research Company Ltd changed from 0 on March 2020 to 0 on March 2024 . This represents a CAGR of 0.0% over 5 years.
  • The Market Cap of Glenmark Pharmaceuticals Ltd changed from ₹ 5814 crore on March 2020 to ₹ 27019 crore on March 2024 . This represents a CAGR of 35.97% over 5 yearsThe Market Cap of Sun Pharma Advanced Research Company Ltd changed from ₹ 5823 crore on March 2023 to ₹ 12005 crore on March 2024 . This represents a CAGR of 43.58% over 2 years.
  • The revenue of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 3267 crore as compare to the Dec '24 revenue of ₹ 3418 crore. This represent the decline of -4.41% The revenue of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ 27.19 crore as compare to the Dec '24 revenue of ₹ 15.1 crore. This represent the growth of 80.07%.
  • The ebitda of Glenmark Pharmaceuticals Ltd for the Mar '25 is ₹ 199.89 crore as compare to the Dec '24 ebitda of ₹ 631.36 crore. This represent the decline of -68.34% The ebitda of Sun Pharma Advanced Research Company Ltd for the Mar '25 is ₹ -53.18 crore as compare to the Dec '24 ebitda of ₹ -73.5 crore. This represent the decline of -27.65%.
  • The net profit of Glenmark Pharmaceuticals Ltd changed from ₹ 173.13 crore to ₹ 4.38 crore over 8 quarters. This represents a CAGR of -84.09% The net profit of Sun Pharma Advanced Research Company Ltd changed from ₹ -95.35 crore to ₹ -59.77 crore over 8 quarters. This represents a CAGR of -20.83% .
  • The Dividend Payout of Glenmark Pharmaceuticals Ltd changed from 5.21 % on March 2020 to 1.37 % on March 2024 . This represents a CAGR of -23.44% over 5 yearsThe Dividend Payout of Sun Pharma Advanced Research Company Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Glenmark Pharmaceuticals Ltd

  • Glenmark Pharmaceuticals Limited was incorporated on November 18, 1977.
  • The Company is actively involved in the discovery of new molecules both NCEs (new chemical entity) and NBEs (new biological entity).
  • It is engaged in the business of development, manufacture and marketing of pharmaceutical products both formulation and active pharmaceuticals ingredients to regulated and semi-regulated markets.
  • The Company's research and development facilities are located at Mahape, Sinnar and Taloja and manufacturing facilities are located at Nasik, Colvale, Baddi, Nalagarh, Sikkim, Indore and Aurangabad in India. The company has several molecules in various stages of pre-clinical and clinical development primarily focused in the areas of Oncology, Respiratory and Dermatology.
  • Its branded generics business has a significant presence in markets across emerging economies including India.

About Sun Pharma Advanced Research Company Ltd

  • Sun Pharma Advanced Research Company Limited (SPARC) is a clinical stage bio-pharmaceutical company engaged in creating new drugs and delivery systems.
  • The Company works on innovation and new product development for global markets.
  • They undertake projects in research and technology for new chemical entities (NCE's) or new molecules, and novel drug delivery systems (NDDS). Sun Pharmaceutical Advanced Research Company Limited was incorporated on March 1, 2006 as an innovative and development company.
  • They commenced operations on March 22, 2006.
  • As per Scheme of Arrangement, all assets and liabilities of the Innovative Research & Development business including Novel Drug Delivery System (NDDS) division of Sun Pharmaceuticals Industries' Research & Development undertaking was transferred and vested into the Company with effect from February 28, 2007.

Glenmark Pharmaceuticals Ltd News Hub

News

Glenmark Pharmaceuticals Ltd up for five straight sessions

Glenmark Pharmaceuticals Ltd rose for a fifth straight session today. The stock is quoting...

Read more

16 Jul 2025 13:00

News

Glenmark Pharma receives warning letter from USFDA for Indore facility

The USFDA inspection was conducted between 3 February and 14 February 2025. In an official...

Read more

14 Jul 2025 10:08

News

Glenmark Pharmaceuticals Ltd up for third consecutive session

Glenmark Pharmaceuticals Ltd is up for a third straight session today. The stock is quotin...

Read more

14 Jul 2025 13:05

News

Glenmark Pharma soars on AbbVie licensing deal for cancer therapy ISB 2001

The announcement follows a major licensing agreement with U.S. biopharma giant AbbVie. Und...

Read more

11 Jul 2025 11:54

News

Glenmark Pharmaceuticals Ltd leads gainers in 'A' group

Netweb Technologies India Ltd, Globus Spirits Ltd, VST Industries Ltd and Jaiprakash Power...

Read more

11 Jul 2025 12:00

News

IGI Therapeutics SA and AbbVie enter into an exclusive licensing agreement for ISB 2001

IGI Therapeutics SA, a wholly owned subsidiary of New York-based Ichnos Glenmark Innovatio...

Read more

10 Jul 2025 19:51

Sun Pharma Advanced Research Company Ltd News Hub

News

Sun Pharma Advanced Research Company to convene AGM

Sun Pharma Advanced Research Company announced that the 20th Annual General Meeting(AGM) o...

Read more

09 Jul 2025 10:11

News

Sun Pharma Advanced Research Company Ltd leads losers in 'A' group

Aditya Birla Fashion & Retail Ltd, Fusion Finance Ltd Partly Paidup, Alivus Life Sciences ...

Read more

04 Jun 2025 15:00

News

SPARC tanks after psoriasis, eczema drug flunks Phase 2 trials

In a regulatory filing, SPARC said that its partner, Sun Pharmaceutical Industries (SPIL),...

Read more

04 Jun 2025 15:02

News

Sun Pharma Advanced Research Company to table results

Sun Pharma Advanced Research Company will hold a meeting of the Board of Directors of the ...

Read more

13 May 2025 15:59

News

Sun Pharma Advanced Research Company submits IND application to USFDA

Sun Pharma Advanced Research Company announced submission of an Investigational New Drug (...

Read more

31 Mar 2025 10:19

News

SPARC submits application for its ADC to US FDA to conduct global phase-1 study

The IND application supports the next phase of development of SBO-154 which has completed ...

Read more

31 Mar 2025 13:58

SWOT Analysis Of Glenmark Pharmaceuticals Ltd

Strength

4

S

Weakness

2

W

Opportunity

1

O

Threats

1

T

SWOT Analysis Of Sun Pharma Advanced Research Company Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Glenmark Pharmaceuticals Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sun Pharma Advanced Research Company Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Glenmark Pharmaceuticals Ltd and Sun Pharma Advanced Research Company Ltd

Which company has a larger market capitalization, Glenmark Pharmaceuticals Ltd or Sun Pharma Advanced Research Company Ltd?

Market cap of Glenmark Pharmaceuticals Ltd is 62,844 Cr while Market cap of Sun Pharma Advanced Research Company Ltd is 5,266 Cr

What are the key factors driving the stock performance of Glenmark Pharmaceuticals Ltd and Sun Pharma Advanced Research Company Ltd?

The stock performance of Glenmark Pharmaceuticals Ltd and Sun Pharma Advanced Research Company Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Glenmark Pharmaceuticals Ltd and Sun Pharma Advanced Research Company Ltd?

As of July 16, 2025, the Glenmark Pharmaceuticals Ltd stock price is INR ₹2226.95. On the other hand, Sun Pharma Advanced Research Company Ltd stock price is INR ₹162.3.

How do dividend payouts of Glenmark Pharmaceuticals Ltd and Sun Pharma Advanced Research Company Ltd compare?

To compare the dividend payouts of Glenmark Pharmaceuticals Ltd and Sun Pharma Advanced Research Company Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions